Search Results 1241-1250 of 19927 for Receptor

1. Clinical trials - Oncology (Medical)

   ... receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2-) advanced or metastatic breast cancer that has progressed on treatment with ...

2. Evaluation Of Rate Adaptive Pacing On Chronotropic Response In Preserved Ejection Fraction HF - Mayo Clinic

   ... receptor antagonist (MRA); LVEF ≥ 45% within previous 12 months. Acceptable methods include echo, ventriculogram (angiography or nuclear), nuclear stress ...

3. Alleviation By Fisetin Of Frailty, Inflammation, And Related Measures In Older Women - Mayo Clinic

   estrogen (E) therapy or treatment with a selective E receptor modulator, or teriparatide (within the past year). Subjects with a fracture within the past ...

4. Unleashing viruses aimed at killing cancer - Mayo Clinic News Network

   Vile's team is combining oncolytic viruses with chimeric antigen receptor T-cell therapy (CAR-T cell therapy) to target solid tumors from liver cancer. This ...

5. Intrinsic tactile sensitivity within the GI tract linked to the activity of specialized sensory enteroendocrine cells - Mayo Clinic

   "We discovered the receptors but need to define the sensory circuit, understand the mechanisms of touch sensing, and explore this in healthy humans and in ...

6. Can a lack of sleep cause high blood pressure? - Mayo Clinic

   Alcohol: Does it affect blood pressure? Alpha blockers · Amputation and diabetes: How to protect your feet · Angiotensin II receptor blockers · Angiotensin ...

7. Late-night eating: OK if you have diabetes? - Mayo Clinic

   Alcohol: Does it affect blood pressure? Alpha blockers · Amputation and diabetes: How to protect your feet · Angiotensin II receptor blockers · Angiotensin- ...

8. Discovery's Edge: Cleaning up cancer - Mayo Clinic News Network

   Dr. Knutson's vaccine heightens the body's response to folate receptor alpha, a protein that has very limited expression in the body but is common in a variety ...

9. A Study Of Imlunestrant Versus Standard Endocrine Therapy In Participants With Early Breast Cancer - Mayo Clinic

   ... receptor positive (ER+) and human epidermal receptor 2 negative (HER2-). Participants must have already taken endocrine therapy for two to five years and ...

10. Study of Cabozantinib Combined With Atezolizumab Vs. Second Novel Hormonal Therapy in Subjects with Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

    nilutamide, bicalutamide, enzalutamide, or other androgen-receptor inhibitors within 2 weeks before randomization - Radiation therapy within 4 weeks (2 ...